Purchase Order 75N93025P00790

Award Date 3/30/25
Potential Completion Date 5/30/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Newark, CA 94560, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,793.20 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company specializing in RNA detection technologies. The contract is for the delivery of 12 custom RNAscope probes and an RNAscope fluorescent reagent kit, which will support various biomedical research efforts across NIAID and...
This is a $15,515.60 firm-fixed-price purchase order contract awarded to Advanced Cell Diagnostics, Inc. (ACD) by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, for the delivery of RNA probes. ACD is a molecular diagnostics company specializing in RNA detection technologies and has received numerous awards from various NIH institutes. This contract supports NIAID's biomedical research efforts, particularly in areas such as infectious diseases, by...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company specializing in RNA detection technologies. The $120.00 contract is for the procurement of AMBIS 1770629 RNAscope H202 & Protease Plus Reagents, a product used to support biomedical research efforts across various NIH institutes and other federal...
This firm-fixed-price purchase order, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Cell Diagnostics, Inc. (ACD), provides the RNASCOPE 2.5 VS REAGENT KIT, BROWN. The $8,037.20 contract is for the supply of ACD's proprietary RNA detection technology to support biomedical research efforts across various NIH institutes. As a subsidiary of Bio-Techne Corporation, ACD specializes in...
This federal contract award, valued at $3,820.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of molecular diagnostics products. The contract is for the provision of reagents and supplies necessary for performing an assay on the Ventana Discovery Ultra Stainer. This purchase order contract is a firm-fixed-price arrangement with no...
This $4,960 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company that specializes in RNA detection technologies. The contract is for the provision of reagent kits, which ACD supplies to support biomedical research efforts across various National Institutes of Health (NIH) institutes and other federal agencies. ACD's proprietary RNAscope technology and related...
This is a firm-fixed-price purchase order contract awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of goods specializing in advanced RNA detection technologies. The $11,208.00 contract is for the provision of 8 kits of reagents for RNAscope experiments, which are critical for biomedical research efforts across various...
This $20,120 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services' National Institutes of Health, to Advanced Cell Diagnostics, Inc. (doing business as ACD) for RNA SCOPE products and services. ACD, a subsidiary of Bio-Techne Corporation (doing business as Bio-Techne), will serve as the prime contractor. The contract period of performance spans from September 20, 2023 through...
This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a subsidiary of Bio-Techne Corporation. The $18,690.00 contract provides ACD's proprietary RNAscope assay biological products, including kits, reagents, and probes, to support various biomedical research efforts across NIH. These products enable the visualization and...
This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD) for the delivery of reagent kits. The contract has a ceiling value of $5,042.00 and an ultimate completion date of December 21, 2015. ACD is a molecular diagnostics company specializing in RNA detection technologies, and its proprietary RNAscope technology has been utilized in...

This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $14,120.00, is for the procurement of RNAscope probes and detection kits to support ongoing research within NIAID's Laboratory of Malaria and Vector Research Mosquito Immunity & Vector Competence Section. The prime contractor is Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of specialized molecular diagnostics products, particularly their proprietary RNAscope technology, which enables precise visualization and quantification of RNA biomarkers. This contract supports critical research initiatives, including studies examining complex biological mechanisms related to infectious diseases, and does not have a set-aside designation.

Generated 7/1/25, 4:25 AM